• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Research

Independent equity research and analysis from our analyst team

Research

Independent equity research and analysis from our analyst team

Apetit: Valuation cooled down a notch
Research6 hours ago by
Kaisa Vanha-Perttula, Pauli Lohi

Apetit: Valuation cooled down a notch

The valuation of the stock has moderated due to the share price decline, but cost pressures limit the visibility of an earnings turnaround.

Apetit
Alexandria Extensive Report: The strategy is taking the company in the right direction
Extensive research17 hours ago by
Sauli Vilén

Alexandria Extensive Report: The strategy is taking the company in the right direction

Alexandria's valuation is cheap, and the potential success of asset management offers a potential bonus.

Alexandria Group
Solwers: Covenant knot tightens as earnings development falters
Research6/18/2026, 7:08 AM by
Olli Vilppo

Solwers: Covenant knot tightens as earnings development falters

Solwers withdrew its guidance yesterday, suggesting that a critical earnings improvement may not materialize this year. We lowered our estimates.

Solwers

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Talenom extensive report: Finland stands firm, international turnaround is key
Extensive research6/18/2026, 2:39 PM by
Juha Kinnunen

Talenom extensive report: Finland stands firm, international turnaround is key

Talenom's Finnish core business continues to reliably generate strong cash flow, but investors doubt the sensibility of international growth. Profitability turnarounds in Spain and Sweden could also reverse the share price development.

Talenom
Finnair omfattande analys: Mot lönsam tillväxt på blåvita vingar
Extensive research6/17/2026, 6:23 PM by
Antti Viljakainen, Kaisa Vanha-Perttula

Finnair omfattande analys: Mot lönsam tillväxt på blåvita vingar

Under sin nya strategiperiod strävar Finnair efter lönsam tillväxt och att stärka intäkterna utanför biljetterna, samtidigt som bolaget genomför en förnyelse av sin flygplansflotta med smalflygplan.

Finnair
H&M Q2'26 preview: Soft topline, but margins resilient so far
Research6/17/2026, 4:30 AM by
Lucas Mattsson

H&M Q2'26 preview: Soft topline, but margins resilient so far

We believe revenue growth remained soft in H&M's Q2, driven by weak market data, reflecting softer consumer confidence and cold weather in April.

H&M
Oriola omfattande analys: Tålamod som recept
Extensive research6/17/2026, 4:30 AM by
Rauli Juva

Oriola omfattande analys: Tålamod som recept

Oriolas aktie ser billig ut, men det finns tydliga risker kopplade till både balansräkningen och den operationella verksamheten.

Oriola
Kreate: Strong outlook materializes into growth
Research6/17/2026, 6:20 AM by
Atte Jortikka

Kreate: Strong outlook materializes into growth

We find the pricing still seems reasonable, considering our significantly raised earnings estimates and the expectation of substantial earnings growth.

Kreate Group
Scanfil extensive report: Good quality with full short-term pricing
Extensive research6/17/2026, 3:52 PM by
Antti Viljakainen

Scanfil extensive report: Good quality with full short-term pricing

We raise our target price for Scanfil to EUR 12.50 (was 11.50 €) on the heels of slightly increased long-term growth estimates. Following the robust progress of the share price over the past year, the positive earnings growth projected in our forecasts has already been factored into the share. In our view, this narrows Scanfil's short-term expected return, even though the long-term story remains quite attractive.

Scanfil
KPY: Framgångsrikt noterat mitt i ett strategiskt skifte
Extensive research6/16/2026, 6:42 AM by
Frans-Mikael Rostedt

KPY: Framgångsrikt noterat mitt i ett strategiskt skifte

KPY övergår för närvarande från att vara en traditionell balansräkningsinvesterare mot en hybrid av balansräkningsinvesterare och fondförvaltare, då bolaget samlar en ny kapitalplaceringsfond och siktar även på infrastrukturfonder.

KPY
Admicom: Mild vinstvarning för estimat
Research6/16/2026, 4:00 AM by
Atte Riikola

Admicom: Mild vinstvarning för estimat

Samtalet inför den tysta perioden behandlade den senaste vinstvarningen.

Admicom
Nightingale: We factored the project delay into our estimates
Research6/12/2026, 7:20 AM by
Antti Siltanen, Antti Luiro

Nightingale: We factored the project delay into our estimates

The revenue outlook for the next fiscal year exceeds 10 MEUR.

Nightingale Health
Puuilo Q1'26: Spot on
Research6/12/2026, 6:09 AM by
Arttu Heikura

Puuilo Q1'26: Spot on

Virtually all of the company's key metrics developed in a more positive direction.

Puuilo
Kemira: Ökade kostnader urholkar marginalen
Research6/11/2026, 5:10 AM by
Petri Gostowski

Kemira: Ökade kostnader urholkar marginalen

Kemira utfärdade på onsdagen en vinstvarning, med hänvisning till ökade råvaru- och transportkostnader orsakade av kriget i Iran.

Kemira
Suominen: Share issue in figures, valuation still high
Research6/11/2026, 6:12 AM by
Rauli Juva

Suominen: Share issue in figures, valuation still high

We updated the impact of the share issue on our estimates, but operationally our assumptions remained unchanged.

Suominen
Hafnia (Investment case): Q1 2026 delivers strong cash flow and dividends amid geopolitical disruption
Research6/10/2026, 2:10 PM by
Rasmus Køjborg, William Jørck

Hafnia (Investment case): Q1 2026 delivers strong cash flow and dividends amid geopolitical disruption

Following Hafnia's Q1 2026 quarterly report, we have updated our investment case on the company. Our updated investment case covers the key investment reasons, risks, and valuation perspective relative to product tanker peers.

Hafnia
Sitowise Group: Divestment drops Swedish millstone
Research6/10/2026, 7:14 AM by
Olli Vilppo

Sitowise Group: Divestment drops Swedish millstone

Sitowise announced yesterday that it is selling its Swedish technical consulting operations to Sweco.

Sitowise Group
Keskisuomalainen omfattande analys: Utdelning och digital omställning i fokus för berättelsen
Extensive research6/10/2026, 4:10 AM by
Arttu Heikura

Keskisuomalainen omfattande analys: Utdelning och digital omställning i fokus för berättelsen

Investeringscaset är beroende av en lyckad digital omställning och anpassning av den vikande verksamheten.

Keskisuomalainen
Duell omfattande analys: Söker en U-sväng
Extensive research6/9/2026, 6:23 AM by
Tommi Saarinen

Duell omfattande analys: Söker en U-sväng

Vi har höjt våra estimat för innevarande år, men balansräkningen förblir stram.

Duell
Terveystalo: Ytterligare styrka söks från optikverksamheten
Research6/9/2026, 4:00 AM by
Roni Peuranheimo

Terveystalo: Ytterligare styrka söks från optikverksamheten

I och med förvärven av Silmäasema och Hohde rör sig Terveystalo från att vara en stabil utdelare mot en tydligare tillväxtinriktning.

Terveystalo